Hematology
Volume 28, 2023 - Issue 1
Open access
1,053
Views
0
CrossRef citations to date
0
Altmetric
Research Article
Treatment preferences towards thrombopoietin-receptor agonists for immune thrombocytopenia and experience of disease (TRAPeze): Italy cohort
Alessandro Lucchesia Hematology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, ItalyView further author information
, Barbara Lovrencicb Associazione Italiana Porpora Immune Trombocitopenica (AIPIT), Caprino Veronese, ItalyView further author information
, Vickie McDonaldc Department of Clinical Haematology, The Royal London Hospital, Barts Health NHS Trust, London, UKView further author information
, Adrian Newlandd Academic Haematology Unit, Blizard Institute, Barts & The London School of Medicine & Dentistry, Queen Mary Institute of London, London, UKView further author information
, Mervyn Morgane ITP Support Association, Bolnhurst, Bedfordshire, UKView further author information
, Daniel Erikssonf Swedish Orphan Biovitrum AB, Stockholm, SwedenView further author information
, Koo Wilsonf Swedish Orphan Biovitrum AB, Stockholm, SwedenView further author information
, Giulio Giordanog Division of Internal Medicine, Hematology Service, Regional Hospital “A. Cardarelli”, Campobasso, ItalyView further author information
, Giuseppe Carlih Department of Hematology, S. Bortolo Hospital, Vicenza, ItalyView further author information
, Emma Geldmani Wickenstones Ltd, Abingdon, UKView further author information
, Owen Daykin-Ponti Wickenstones Ltd, Abingdon, UKCorrespondence[email protected]
View further author information
, View further author information
Samantha Princei Wickenstones Ltd, Abingdon, UKView further author information
& Mariasanta Napolitanoj Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, ItalyView further author information
show all
Article: 2253069
|
Received 14 Apr 2023, Accepted 24 Aug 2023, Published online: 07 Sep 2023
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.